Related Experiment Video
Updated: Jun 16, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
Published on: November 5, 2019
von Willebrand factor activation, granzyme-B and thrombocytopenia in meningococcal disease
M J Hollestelle1, T Sprong, N Bovenschen
1Department of Clinical Chemistry and Haematology, University Medical Centre Utrecht, Utrecht, the Netherlands. J.Hollestelle@umcutrecht.nl
Summary Background:
During invasive meningococcal disease, severe thrombocytopenia is strongly associated with a poor outcome.
Objectives:
In order to elucidate the pathophysiological mechanism behind the development of thrombocytopenia, we studied the role of von Willebrand factor (VWF) in meningococcal disease.
Patients/Methods:
Thirty-two children with severe meningococcal disease admitted to our university hospital were included in this study. VWF and related parameters were measured and results were correlated with the development of shock and thrombocytopenia.
Results:
At admission, all patients had increased levels of (active) VWF and VWF propeptide. The highest VWF propeptide levels were observed in patients with shock, indicating acute endothelial activation. Although VWF propeptide levels in patients with shock, with or without thrombocytopenia, were similar, increased active VWF was significantly lower in patients with thrombocytopenia as compared with patients without thrombocytopenia. ADAMTS13 was moderately decreased. However, the VWF multimeric pattern was minimally increased. We assume that these findings are explained by VWF consumption and perhaps by granzyme B (GrB). In vitro experiments showed that GrB is able to cleave VWF multimers in plasma, whereas GrB was high in patients with shock, who developed thrombocytopenia.
Conclusions:
Our results demonstrate that consumption of VWF, derived from endothelial cells, could be a key feature of meningococcal disease and primary to the development of thrombocytopenia during shock.
Insights
Severe thrombocytopenia in meningococcal disease is linked to poor outcomes. This study reveals that von Willebrand factor (VWF) consumption, potentially due to granzyme B, drives thrombocytopenia during shock in this condition.
Area of Science:
- Hematology
- Infectious Diseases
- Pediatrics
Background:
- Severe thrombocytopenia is a poor prognostic indicator in invasive meningococcal disease.
- Understanding the mechanisms of thrombocytopenia is crucial for improving patient outcomes.
Purpose of the Study:
- To investigate the role of von Willebrand factor (VWF) in the development of thrombocytopenia during meningococcal disease.
- To elucidate the pathophysiological mechanisms linking VWF to meningococcal-associated thrombocytopenia.
Main Methods:
- Studied 32 children with severe meningococcal disease.
- Measured VWF and related parameters, correlating them with shock and thrombocytopenia.
- Conducted in vitro experiments to assess the effect of granzyme B (GrB) on VWF.
Main Results:
- All patients exhibited elevated levels of active VWF and VWF propeptide upon admission.
- Highest VWF propeptide levels indicated acute endothelial activation, particularly in patients with shock.
- Active VWF levels were lower in patients with thrombocytopenia, suggesting VWF consumption, possibly aided by GrB, which was elevated in shock patients.
Conclusions:
- VWF consumption, originating from endothelial cells, is a primary factor in the development of thrombocytopenia during meningococcal shock.
- Granzyme B may play a role in VWF cleavage, contributing to thrombocytopenia.
Related Concept Videos
Bacterial Meningitis II: Pathophysiology
Bacterial Meningitis
Bacterial Meningitis I: Introduction
Cryptococcal Meningitis
Viral Meningitis
Determinants of Bacterial Pathogenicity and Virulence

